The global anastomosis devices market was valued at USD 2,076.4 million in 2018. Increase in prevalence of cardiovascular and gastrointestinal disorders, rapidly growing volume of coronary artery bypass surgery (CABG), and bowel resection surgeries performed across the globe are key factors driving the global anastomosis devices market.
Anastomosis is a surgical connection between two tubular structures, such as blood vessels or loops of intestine during surgical procedures. There are two major forms of anastomoses namely, vascular and gastrointestinal anastomosis. Vascular anastomosis is performed to connect the blood vessels during cardiac surgeries; whereas, gastrointestinal anastomosis is performed for bowel resection. Aggravating chronic ailments such as cardiovascular and gastrointestinal disorders such as colorectal cancer leads to increase in surgical volume. This, in turn, drives the demand for anastomosis devices including surgical staplers and sutures.
Moreover, rapid technological advancements in surgical staplers and sutures, increase in demand for minimally invasive procedures across the globe is expected to drive the growth of anastomosis devices market in the future. However, complications associated with anastomosis procedure such as anastomosis leaks may hinder the growth of the market over the forecast period.
The global anastomosis devices market is categorized based on product, application, end-users, and region. On the basis of product, surgical staplers segment held the largest share of the global anastomosis devices market in 2018 owing to wide adoption of powered and circular stapling devices during complex surgeries. By end-users, ambulatory surgical centers (ASCs) & clinics segment is anticipated to grow at a lucrative rate over the forecast period. Geographically, North America dominated the global anastomosis devices market in 2018, however, Asia Pacific is expected to be the fastest growing region by 2025.
Key players operating in the global anastomosis devices market include Ethicon Inc. (Johnson & Johnson), Medtronic plc, B. Braun Melsungen AG, MAQUET Holding B.V. & Co. KG., Novare Surgical Systems, Inc., Vitalitec International Inc., Synovis Micro Companies Alliance, Inc., LivaNova PLC, and CryoLife among others.
Key Segments of the Global Anastomosis Devices Market
Product Overview, 2015-2025 (USD Million)
- Surgical Staplers
- Manual Surgical Staplers
- Powered Surgical Staplers
- Circular Surgical Staplers
- Surgical Sutures
- Absorbable Sutures
- Non-absorbable Sutures
- Automatic Suturing Devices
- Surgical Sealants & Adhesives
- Natural/Biological Sealants & Adhesives
- Synthetic Sealants & Adhesives
Application Overview, 2015-2025 (USD Million)
- Cardiovascular Surgeries
- Gastrointestinal Surgeries
End-users Overview, 2015-2025 (USD Million)
- Ambulatory Surgical Centers (ASCs) & Clinics
Regional Overview, 2015-2025 (USD Million)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
Reasons for the study
- Increase in incidence of chronic disorders such as cardiovascular and gastrointestinal diseases
- Rapid technological advancements in anastomosis devices industry
- Surging demand for minimally invasive procedures
What does the report include?
- The study on the global anastomosis devices market includes qualitative insights such as drivers, restraints, challenges and opportunities
- Additionally, the market has been evaluated using the Porter’s Five Forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of product, application, and end-users. Moreover, the study on anastomosis devices market provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players operating in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global anastomosis devices market is suitable for all the players across the value chain including raw material suppliers, hospitals, clinics, ambulatory surgical centers, medical device manufacturers, healthcare organizations, distributors, suppliers and application geeks
- Venture capitalists and investors looking for more information on the future outlook of the global anastomosis devices market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global anastomosis devices market
Anastomosis devices play a significant role in surgical procedures. Major forms of anastomosis include vascular and gastrointestinal. HEARTSTRING II Proximal Seal System, PAS-Port Proximal Anastomosis System, Enclose II Anastomosis Assist Device and C-Port Distal Anastomosis Systems are some most prominent anastomosis devices available in the market. The need for anastomosis devices has significantly increased owing to rapidly growing volume of surgical procedures. According to HonorHealth, approximately 500,000 coronary artery bypass surgery (CABG) procedures are performed in the U.S. Cardiac and gastrointestinal disorders such as colorectal cancer determine huge healthcare burden. Rapid rise in prevalence of such chronic disorders will propel demand for surgical procedures. This, in turn, will elevate the number of surgical site infections post surgeries. Anastomosis devices such as sutures, staplers, sealants and adhesives help to treat large wounds caused post-surgery, thereby reducing the risk of infections at the surgical site. Moreover, major industry players are also investing in R&D to develop technologically advanced anastomosis devices.
The global anastomosis market has been segmented based on product, application, end-user, and region. Based on products, the anastomosis market is segmented into surgical sutures, surgical staplers, and surgical sealants and adhesives. Surgical sutures are sub-categorized into absorbable sutures, non-absorbable sutures, and automatic suturing devices. Surgical staplers segment is further classified for manual, powered, and circular surgical staplers. Surgical sealants and adhesives segment is sub-classified into natural/biological and synthetic sealants and adhesives. Surgical staplers segment held majority of the market share in 2018 owing to advantages such as quick placement, ease of use, accurate wound closure, and minimal interaction with the tissue, shorter operating time, and minimum risk of infections. Moreover, rapid adoption of powered and circular surgical staplers over manually operated surgical stapling devices is other factor anticipated to fuel the growth of the segment in the future.
On the basis on application, the global anastomosis market is categorized into gastrointestinal surgeries, cardiovascular surgeries and others. Gastrointestinal surgeries held substantial share of the market in 2018 owing to numerous colorectal surgeries performed across the globe. Anastomosis products are majorly adopted in hospitals, ambulatory surgical centers and clinics. Hospitals dominated the global anastomosis market in 2018 owing to increase in adoption of anastomosis devices during surgical procedures.
The global anastomosis devices market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global anastomosis devices market in 2018, however Asia Pacific is expected to grow at a highest pace through 2025.
Increase in incidence of cardiovascular and gastrointestinal diseases along with surging volume of surgeries performed in the U.S. are major factors expected to drive the demand for anastomosis devices in the region. For instance, about 500,000 colectomies are performed annually in the country which is expected to rise owing to rapidly growing geriatric population. Of these, 32% account for colorectal cancer surgeries whereas, 68% are performed for non-cancerous diseases. Additionally, colorectal surgery is the second-leading readmission procedure in the U.S. posing huge cost burden. Moreover, favorable reimbursement policies along with large volume of CABG procedures performed in the U.S. will increase the demand for anastomosis devices in the future. These factors are likely to boost the growth of the market in North America.
However, Asia Pacific is expected to grow at a rapid pace over the next few years. There is a strong growth potential in the emerging economies such as India, and China. The rapidly rising geriatric population, surge in incidence of chronic ailments along with growing demand for minimally invasive surgeries in countries such as India and China provide as large market for anastomosis devices.